A- A A+

Kanada. CRISM National Guideline for the Clinical Management of Opioid Use Disorder / Lignes Directrices Nationales de L’Initiative Canadienne de Recherche sur L’Abus de Substances Du Trouble Li é à L’usage D’opioïdes, 2018


Working with people who use drugs - Guidance for homelessness accommodation services

There is no legal requirement for homelessness services to provide specific support to individuals who use drugs, although it is common for people experiencing homelessness to be using drugs. Homelessness services vary in their tolerance to drug use, and the use of drugs can cause challenges for clients who are expected to adhere to organisational policies and procedures. This can be equally challenging for the organisation. There is, however, an opportunity for homelessness services to work with people using drugs, in order to help reduce harm, improve future prospects and increase opportunities of re-integration in to wider society. (homeless link, UK, Mai 2019)


Schweiz. Hepatitis C bei Drogenkonsumierenden: Richtlinien mit settingspezifischen Factsheets.

Bundesamt für Gesundheit, Infodrog. Bern: Bundesamt für Gesundheit, 2019.


Evidence-Based Guidelines for EMS Administration of Naloxone.

Williams K, Lang ES, Panchal A, Gasper JJ, Taillac P, Gouda J, Hedges M.

Prehosp Emerg Care. 2019 Mar 29:1-41. doi: 10.1080/10903127.2019.1597955. 


Methadone Safety: A Clinical Practice Guideline From the American Pain Society and College on Problems of Drug Dependence, in Collaboration With the Heart Rhythm Society

Chou, Roger et al.

The Journal of Pain , Volume 15 , Issue 4 , 321 - 337 


EACS-HIV-LEITLINIEN - Version 9.1 - Oktober 2018 – Englisch

EACS produces the European Guidelines for treatment of HIV-positive adults in Europe. The English version is regularly updated by the guideline panels. A major update is published once per year in autumn and translated into additional languages. (European AIDS Clinical Society / EACS)


HIV. Neue EACS Leitlinien 

Die Europäische Aids-Gesellschaft hat im Oktober die Leitlinien aktualisiert. Dabei folgt sie mehr denn je internationalen Trends. Hier die wichtigsten Neuerungen.(Die deutsche Übersetzung liegt noch nicht vor, Anm. Forum Substitutionspraxis) (hiv&more, Ausgabe 4/2018)


EMCDDA/CCSA. Cannabis und Führen eines Kraftfahrzeugs: Fragen und Antworten für das Finden einer politischen Entscheidung

Europäische Beobachtungsstelle für Drogen und Drogensucht und Canadian Centre on Substance Use and Addiction (2018), Amt für Veröffentlichungen der Europäischen Union, Luxemburg


PEP – Leitlinien Update 2018: Deutsch-Österreichische Leitlinien zur HIV-Postexpositionsprophylaxe

Die wichtigste Änderung betrifft die empfohlenen Medikamente zur PEP. (Zusammenfassung in: hiv&more, Ausgabe 3/2018)


Charité. Mustercurriculum Patientensicherheit der Weltgesundheitsorganisation. Multiprofessionelle Ausgabe. 

Charité – Universitätsmedizin Berlin (Hg.) (2018): Berlin: Charité – Universitätsmedizin Berlin, ISBN: 978-3-00-060626-7


WHO legt Leitlinie zur somatischen Versorgung psychisch Kranker vor

Genf – Menschen mit schweren psychischen Störungen – mittelschwere bis schwere Depressionen, bipolare Störungen, Schizophrenie und andere psychotische Störungen – haben in der Regel eine Lebenserwartung, die zehn bis 20 Jahre kürzer ist als die der allgemeinen Bevölkerung. Darauf weist die Weltgesundheitsorganisation WHO hin. Die Mehrheit dieser vorzeitigen Todesfälle sei auf somatische Erkrankungen zurückzuführen. (aerzteblatt.de, 09.11.2018)


WHO Guidelines. Management of physical health conditions in adults with severe mental disorders

World Health Organization, Publication date: 2018, Languages: English, ISBN: 978-92-4-155038-3


EMCDDA. Best Practice Portal (Deutsch)

Das Best Practice Portal (Portal für vorbildliche Verfahren) soll Ihnen bei der Suche nach praktischen und verlässlichen Informationen über erfolgreiche (und wirkungslose) Maßnahmen in den Bereichen Prävention, Behandlung, Schadensminimierung und soziale Wiedereingliederung helfen. Hier können Sie schnell bewährte Interventionen ermitteln, Ihre Ressourcen effektiv planen und Ihre Maßnahmen durch die Anwendung von Tools, Standards und Leitlinien verbessern. (EMCDDA, Lissabon, Oktober 2018)


Opioid agonist treatment Guiding principles for legislation and regulations (Pompidou Group)

Expert group on the regulatory framework for the treatment of opioid dependence syndrome and the prescription of opioid agonist medicines. (Pompidou Group/Counsil of Europe, Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs, 2018, engl./frz.)


As the NAS Crisis Worsens, a New Study Offers Treatment Guidelines

The incidence of neonatal abstinence syndrome (NAS) has been climbing steadily, according to a 2016 Morbidity and Mortality Weekly Report from the Centers for Disease Control and Prevention (CDC). The report, published August 12, indicated that the number of NAS cases rose from 1.5 per 1,000 hospital births in 1999 to 6 per 1,000 in 2013.

Yet guidelines for treating NAS have been lacking, according to a study in JAMA Pediatrics. The study, published online June 18, found that although several different approaches are being used, “no universal evidence-based pharmacological treatment strategy exists.” The article also noted that the FDA hasn’t approved any drug for treating infants who have NAS.

The authors of the JAMA Pediatrics study said that, without clear treatment guidelines, caregivers have typically chosen either methadone or morphine to treat their young NAS patients.

New Guidelines

Which medication—methadone or morphine—is better, and how to decide on an appropriate dose? Some studies have suggested basing the dose on the infant’s weight; others, on the severity of NAS, as assessed by the Finnegan Neonatal Abstinence Scoring System.

The JAMA Pediatrics team set out to answer the medication questions. They designed a treatment plan, then carried out what they believe is the first multisite, double-blind, randomized trial comparing the safety and efficacy of methadone and morphine in NAS. They published their results online June 18. (atforum.com, USA, 04.09.2018)


Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion (Version 7 vom 29.11.2017)

Deutsche AIDS-Gesellschaft, Österreichische AIDS-Gesellschaft


USA. Johns Hopkins experts create opioid prescribing guidelines for 20 common surgical procedures

A Johns Hopkins expert panel of health care providers and patients have announced what is, to their knowledge, the nation's first set of operation-specific opioid prescribing guidelines. The guidelines are based on the premise that opioid prescribing limits should be based on the operation performed rather than a blanket approach. The ranges offered for each of 20 common operations generally call for reductions from the current rates of opioid prescription, and the researchers say that patients themselves favor using less of the drugs than physicians often prescribe. (Johns Hopkins University School of Medicine, USA, 14.08.2018)


WHO. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection

WHO, Number of pages: 108; Publication date: July 2018; Languages: English; ISBN: 978-92-4-155034-5

These guidelines aim to provide evidence-based recommendations on the care and treatment of persons diagnosed with chronic HCV infection. They update the care and treatment section of the WHO Guidelines for the screening, care and treatment of persons with hepatitis C infection issued in April 2016. The 2017 Guidelines on hepatitis B and C testing update the screening section.


A survey of tobacco dependence treatment guidelines content in 61 countries

Kapka Nilan, Ann McNeill, Rachael L. Murray, Tricia M. McKeever and Martin Raw 

Addiction, Volume 113, Issue8, August 2018, Pages 1499-1506

First published: 28 February 2018, doi.org/10.1111/add.14204


Simplified guideline for prescribing medical cannabinoids in primary care. 

Allan GM, Ramji J, Perry D, Ton J, Beahm NP, Crisp N, et al. 

Can Fam Physician. 2018;64:111–20. (Eng), e64–75 (Fr).


Inpatient and Outpatient Treatment Programs for Substance Use Disorder: A Review of Clinical Effectiveness and Guidelines [Internet].

Ho C, Adcock L.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Nov 7.


Deutsch-Österreichische Leitlinien zur HIV-Präexpositionsprophylaxe

Klassifikation: S2k, AWMF-Register-Nr.: 055-008, Federführung: Deutsche AIDS-Gesellschaft (DAIG), 24.5.2018


USA. Scientific guidelines for using cannabis to treat stress, anxiety and depression

PULLMAN, Wash.--In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. (Washington State University, 19.04.2018)


Open letter on the UNODC/WHO International Standards for the Treatment of Drug Use Disorders

We, the undersigned civil society organisations working at the national, regional and international level on issues related to drug use, drug treatment, harm reduction and drug policies, are writing to you today regarding the joint UNODC and WHO publication entitled International Standards for the Treatment of Drug Use Disorders.

The ‘Draft for Field Testing’ of this document (March 2017) raises serious concerns and contains significant omissions and misrepresentations. We request your urgent action to prevent these Standards being released in their current state. (Unterzeichnet von 188 Organisationen, 08.03.2018)


International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.

Crunelle CL, van den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, van de Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A; ICASA consensus group, Matthys F.

Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767.


Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline.

Lapoint J, Meyer S, Yu CK, Koenig KL, Lev R, Thihalolipavan S, Staats K, Kahn CA.

West J Emerg Med. 2018 Mar;19(2):380-386. doi: 10.5811/westjem.2017.11.36368.


Niederlande. Richtlijnen: Stoornissen in het gebruik van cannabis, cocaïne, amfetamine, ecstasy, GHB en benzodiazepines

(GGZ Standaarden - Dé online database met alle zorgstandaarden, richtlijnen en generieke modules,Niederlande, 26.02.2018)


Kanada. Management of opioid use disorders: a national clinical practice guideline

Julie Bruneau, Keith Ahamad, Marie-Ève Goyer, Ginette Poulin, Peter Selby, Benedikt Fischer, T. Cameron Wild and Evan Wood; on behalf of the CIHR Canadian Research Initiative in Substance Misuse

CMAJ March 05, 2018 190 (9) E247-E257; doi.org/10.1503/cmaj.170958